Related Experiment Video
Updated: Mar 3, 2026
11:17
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
12.6K
Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern
A Sidoroff1, S Halevy, J N Bavinck
1Department of Dermatology and Venereology, University of Innsbruck, Austria. alexis.sidoroff@uibk.ac.at
Journal of Cutaneous Pathology
|February 13, 2001
Summary
Acute generalized exanthematous pustulosis (AGEP) is a drug-induced skin reaction characterized by pustules on red skin. Early recognition of AGEP is crucial for prompt diagnosis and avoiding unnecessary treatments.
Area of Science:
- Dermatology
- Pharmacology
- Pathology
Background:
- Pustular skin eruptions can stem from various diseases or reactions.
- A distinct subgroup, acute generalized exanthematous pustulosis (AGEP), is primarily drug-induced and has characteristic features.
Purpose of the Study:
- To delineate the clinical presentation and characteristics of AGEP.
- To provide an overview of the disease, its triggers, and diagnostic criteria.
Main Methods:
- Analysis of data from a multinational epidemiological study on severe cutaneous adverse reactions.
- Comprehensive literature review to consolidate existing knowledge on AGEP.
- Presentation of a validated case-finding algorithm for AGEP.
Main Results:
- AGEP manifests as numerous sterile pustules on erythematous, edematous skin, often in folds and on the face.
- Commonly associated with fever and neutrophilia; histopathology reveals subcorneal pustules and dermal edema.
- Acute onset, frequently linked to drug intake, with spontaneous resolution within 15 days.
Conclusions:
- AGEP diagnosis should be considered for acute pustular rashes.
- Identifying the causative agent is essential for management.
- Understanding AGEP's clinical course aids in preventing unneeded interventions.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
64
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
64
01:19Hypersensitivity Reactions: Immune-Complex Reactions
68
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
68
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
91
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
91
01:30Allergic Reactions: Anaphylaxis
86
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
86
01:01Hypersensitivity Reactions: Cytolytic Reactions
74
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
74
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K